We could not find any results for:
Make sure your spelling is correct or try broadening your search.
KalVista Pharmaceuticals Inc is a pharmaceutical company, which focuses on the discovery, development, and commercialization of small molecule protease inhibitors for a range of diseases. The company's product portfolio comprises small molecule plasma kallikrein inhibitors targeting hereditary angio... KalVista Pharmaceuticals Inc is a pharmaceutical company, which focuses on the discovery, development, and commercialization of small molecule protease inhibitors for a range of diseases. The company's product portfolio comprises small molecule plasma kallikrein inhibitors targeting hereditary angioedema and diabetic macular edema; and oral plasma kallikrein inhibitors. Geographically it operates throughout the region of the United States. Show more
TORONTO, Aug. 11, 2022 (GLOBE NEWSWIRE) -- Sprott Asset Management LP (“Sprott Asset Management”), a subsidiary of Sprott Inc., on behalf of the Sprott Physical Gold Trust (NYSE: PHYS) (TSX:...
Period | Change | Change % | Open | High | Low | Avg. Daily Vol | VWAP | |
---|---|---|---|---|---|---|---|---|
1 | -0.12 | -0.821917808219 | 14.6 | 15.5 | 14.12 | 272911 | 14.93505996 | CS |
4 | 2.82 | 24.1852487136 | 11.66 | 15.5 | 11.44 | 362212 | 13.82410201 | CS |
12 | 2.26 | 18.4942716858 | 12.22 | 15.5 | 10.845 | 301855 | 12.6154498 | CS |
26 | 1.1 | 8.22122571001 | 13.38 | 16.88 | 10.105 | 564337 | 13.26503428 | CS |
52 | 4.68 | 47.7551020408 | 9.8 | 16.88 | 7.21 | 438776 | 12.17645469 | CS |
156 | -7.01 | -32.6198231736 | 21.49 | 21.765 | 4.12 | 319565 | 11.1811038 | CS |
260 | -2.86 | -16.493656286 | 17.34 | 45 | 4.12 | 295708 | 16.19720566 | CS |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: 1-888-992-3836 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions